The ongoing escalation of antimicrobial resistance has effectively pushed modern medicine toward a precipice where common infections could once again become untreatable without a fundamental shift in drug discovery. This looming crisis is particularly evident in the treatment of Neisseria
The traditional role of artificial intelligence in healthcare has long been confined to the instantaneous identification of acute symptoms or the classification of medical imagery, but a significant paradigm shift is now underway as systems move toward managing lifelong chronic health conditions.
The traditional pharmaceutical development funnel is currently facing a massive overhaul as researchers move away from static, isolated chemical assays toward dynamic platforms that observe drug behavior within the bustling complexity of living human cells. This transition marks a fundamental
Ivan Kairatov is a distinguished biopharma expert whose career has been defined by a commitment to bridging the gap between cutting-edge technology and real-world patient outcomes. With extensive experience in research and development, Kairatov has spent years navigating the complexities of drug
The conventional diagnostic approach of treating a tumor as a uniform mass of malignant cells has reached a functional ceiling in oncology, necessitating a move toward high-resolution architectural mapping. The Spatial Transcriptomic Tumor Atlas represents a pivotal shift in this landscape, moving
The quest to understand how malignant cells detach from a primary tumor and successfully colonize distant organs has long remained one of the most formidable challenges in modern oncology. While traditional therapies often succeed in shrinking localized masses, the ability of certain cells to evade
